Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00238693 · ClinicalTrials.gov registry record
Transplant Patient Registry of Liver, Kidney and/or Pancreas
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 13,767
- Enrollment target
NCT00238693: Completed study, sponsored by Virginia Commonwealth University.
NCT00238693 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 13,767 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00238693 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 13,767 participants
- Enrollment target
Study Summary
This is a registry of data collected from patient records, both of those who have a condition which may require transplantation and those who have undergone transplantation of the liver, kidney and/or pancreas.
Primary Outcome
MAINTAIN A CURRENT, ACCURATE DATA BASE OF TRANSPLANT RECIPIENTS WITH REGARDS TO TRANSPLANT DATA AND OUTCOMES.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,767 participants |
| Start Date | 2003-04 |
| Est. Completion | 2018-08-27 |
What the finished NCT00238693 record still lists
NCT00238693 is an observational study that tracks outcomes without assigning an intervention. Its 13,767 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00238693 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00238693 about?
NCT00238693 is a clinical study titled "Transplant Patient Registry of Liver, Kidney and/or Pancreas". This is a registry of data collected from patient records, both of those who have a condition which may require transplantation and those who have undergone transplantation of the liver, kidney and/or pancreas.
What is the current status of trial NCT00238693?
This trial is currently completed. The enrollment target is 13,767 participants. The study started on 2003-04. Estimated completion is 2018-08-27.
Who is sponsoring clinical trial NCT00238693?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058767 · 13,764 participants · NA
Preschool Hearing Screening
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
- NCT05591066 · 14,400 participants · NA
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
- NCT05991453 · 13,000 participants · NA
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia